181 related articles for article (PubMed ID: 15041044)
21. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
Gutiérrez-Adrianzén OA; Koutouzov S; Mota RM; das Chagas Medeiros MM; Bach JF; de Holanda Campos H
J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
[TBL] [Abstract][Full Text] [Related]
23. [The comparison of the three anti-dsDNA antibody detecting test].
Tong DW; Zhang SL; Li YZ; Hu CJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):74-5. PubMed ID: 19799026
[TBL] [Abstract][Full Text] [Related]
24. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.
Hung WT; Chen YM; Lan JL; Chen HH; Chen YH; Chen DY; Hsieh CW; Wen MC
Lupus; 2011 Nov; 20(13):1404-10. PubMed ID: 21946514
[TBL] [Abstract][Full Text] [Related]
25. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
[TBL] [Abstract][Full Text] [Related]
26. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
27. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity?
Andreoli L; Pregnolato F; Burlingame RW; Allegri F; Rizzini S; Fanelli V; Radice A; Corace C; Sinico RA; Meroni PL; Tincani A
J Autoimmun; 2008; 30(1-2):51-7. PubMed ID: 18191541
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
Kim KH; Han JY; Kim JM; Lee SW; Chung WT
Clin Chim Acta; 2007 May; 380(1-2):182-5. PubMed ID: 17355877
[TBL] [Abstract][Full Text] [Related]
29. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring.
Villalta D; Romelli PB; Savina C; Bizzaro N; Tozzoli R; Tonutti E; Ghirardello A; Doria A
Lupus; 2003; 12(1):31-6. PubMed ID: 12587824
[TBL] [Abstract][Full Text] [Related]
30. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
Voss A; Nielsen EH; Svehag SE; Junker P
J Rheumatol; 2008 Apr; 35(4):625-30. PubMed ID: 18278838
[TBL] [Abstract][Full Text] [Related]
31. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
[TBL] [Abstract][Full Text] [Related]
32. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
Saisoong S; Eiam-Ong S; Hanvivatvong O
Clin Exp Rheumatol; 2006; 24(1):51-8. PubMed ID: 16539819
[TBL] [Abstract][Full Text] [Related]
33. [Autoantibodies in systemic lupus erythematosus: spectrum and clinical associations].
Haddouk S; Ben Ayed M; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
Pathol Biol (Paris); 2005 Jul; 53(6):311-7. PubMed ID: 16004941
[TBL] [Abstract][Full Text] [Related]
34. High sensitive detection of double-stranded DNA autoantibodies by a modified Crithidia luciliae immunofluorescence test.
Conrad K; Ittenson A; Reinhold D; Fischer R; Roggenbuck D; Büttner T; Bosselmann HP; Steinbach J; Schössler W
Ann N Y Acad Sci; 2009 Sep; 1173():180-5. PubMed ID: 19758148
[TBL] [Abstract][Full Text] [Related]
35. The ananti-alpha-actinin test completes ananti-DNA determination in systemic lupus erythematosus.
Croquefer S; Renaudineau Y; Jousse S; Gueguen P; Ansart S; Saraux A; Youinou P
Ann N Y Acad Sci; 2005 Jun; 1050():170-5. PubMed ID: 16014531
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases.
Uesugi H; Ozaki S; Sobajima J; Osakada F; Shirakawa H; Yoshida M; Nakao K
J Rheumatol; 1998 Apr; 25(4):703-9. PubMed ID: 9558172
[TBL] [Abstract][Full Text] [Related]
37. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
Su Y; Jia RL; Han L; Li ZG
Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P
J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M
Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
[TBL] [Abstract][Full Text] [Related]
40. Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus.
Sallai K; Nagy E; Derfalvy B; Müzes G; Gergely P
Clin Diagn Lab Immunol; 2005 Jan; 12(1):56-9. PubMed ID: 15642985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]